ATNM vs MA · rev $35.0M vs P/E 38, rev $17.68B
Actinium Pharmaceuticals Inc (ATNM) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
ATNM currently screens at market cap $33.9M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the ATNM and MA stock pages for the full models.
Not investment advice.